Cooperation of the Ebola virus proteins VP40 and GP_1,2 with BST2 to activate NF-κB independently of virus-like particle trapping

Keyphrases

• NF-B 100%
• Virus-like 100%
• Ebola Virus Proteins 100%
• VP40 100%
• BST2 100%
• Particle Trapping 100%
• Virion 31%
• Ebola Virus 25%
• Entrapment 25%
• Plasma Membrane 12%
• GPI-anchored Protein (GPI-AP) 12%
• Envelope Glycoprotein 6%
• Human Immunodeficiency Virus Type 1 (HIV-1) 6%
• Cytoplasmic Domain 6%
• Dysregulated 6%
• Signaling Pathway 6%
• Viral Infection 6%
• Inflammatory Pathways 6%
• Host Cell Proteins 6%
• Cysteine 6%
• Antagonism 6%
• Ebola Virus Disease 6%
• Infected Cells 6%
• Dimerization 6%
• Non-pathogenic 6%
• Ectodomain 6%
• Cytokine Response 6%
• Matrix Protein 6%
• Highly Pathogenic 6%
• Ebola Virus Infection 6%
• Dual Function 6%
• Pathogenic Species 6%
• Tetramerization 6%
• Zaire Ebolavirus 6%
• Glycoprotein GP 6%
• Reston Ebolavirus 6%
• Vpu Protein 6%
• Retroviral Assembly 6%

Immunology and Microbiology

• Ebola Virus 100%
• Viral Protein 100%
• Virus-Like Particle 100%
• VP40 100%
• Virion 45%
• Viral Disease 18%
• Cell Membrane 18%
• Glycoprotein 9%
• Human Immunodeficiency Virus 1 9%
• Wild Type 9%
• Matrix Protein 9%
• Cytokine Response 9%
• Vpu 9%
• Dimerization 9%
• Immunoreceptor Tyrosine-Based Activation Motif 9%
• Zaire Ebolavirus 9%
• Cysteine 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Ebola Virus 100%
• Virus Like Agent 100%
• Protein VP40 100%
• Viral Protein 30%
• Virus Infection 20%
• Glycosylphosphatidylinositol 20%
• Cytokine 10%
• Human Immunodeficiency Virus 1 10%
• Glycoprotein 10%
• Cysteine 10%
• Ebola Virus Disease 10%
• Matrix Protein 10%
• Zaire Ebolavirus 10%
• Vpu Protein 10%